|
Alembic Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
16558.48 Cr.
|
P/BV
|
2.83
|
Book Value (Rs.)
|
297.45
|
|
52 Week High/Low (Rs.)
|
998/636
|
FV/ML
|
2/1
|
P/E(X)
|
24.54
|
|
Bookclosure
|
29/07/2026
|
EPS (Rs.)
|
34.33
|
Div Yield (%)
|
1.42
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 693.95 | 707.18 | 631.83 | 354.59 | 620.11 |
| | | | | | |
| Net CashFlow From Operating Activities | 782.73 | 87.97 | 803.20 | 723.95 | 552.36 |
| Net Cash Used In Investing Activities | -506.06 | -568.41 | -320.61 | -447.59 | -371.97 |
| Net Cash Used From Financing Activities | -163.78 | 443.71 | -437.86 | -261.96 | -217.36 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 112.89 | -36.73 | 44.73 | 14.40 | -36.97 |
| Cash And Cash Equivalents Begin of Year | 83.48 | 120.21 | 75.48 | 61.08 | 98.06 |
| Cash And Cash Equivalents End Of Year | 196.37 | 83.48 | 120.21 | 75.48 | 61.09 |